NO783783L - Diagnostisk fremgangsmaate. - Google Patents
Diagnostisk fremgangsmaate.Info
- Publication number
- NO783783L NO783783L NO783783A NO783783A NO783783L NO 783783 L NO783783 L NO 783783L NO 783783 A NO783783 A NO 783783A NO 783783 A NO783783 A NO 783783A NO 783783 L NO783783 L NO 783783L
- Authority
- NO
- Norway
- Prior art keywords
- lymphocytes
- poly
- synthetic peptide
- incubation
- electric field
- Prior art date
Links
- 238000002405 diagnostic procedure Methods 0.000 title claims description 4
- 210000004698 lymphocyte Anatomy 0.000 claims description 26
- 239000002245 particle Substances 0.000 claims description 26
- 238000011534 incubation Methods 0.000 claims description 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 17
- 230000005684 electric field Effects 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 230000005012 migration Effects 0.000 claims description 10
- 238000013508 migration Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims description 5
- 238000000338 in vitro Methods 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- 229960003104 ornithine Drugs 0.000 claims description 2
- 229920000724 poly(L-arginine) polymer Polymers 0.000 claims description 2
- 108010055896 polyornithine Proteins 0.000 claims description 2
- 239000000126 substance Substances 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000012980 RPMI-1640 medium Substances 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- GGGDNPWHMNJRFN-UHFFFAOYSA-N metrizoic acid Chemical compound CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I GGGDNPWHMNJRFN-UHFFFAOYSA-N 0.000 description 1
- 229960004712 metrizoic acid Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/806—Electrical property or magnetic property
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Sink And Installation For Waste Water (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772750521 DE2750521A1 (de) | 1977-11-11 | 1977-11-11 | Diagnostisches verfahren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO783783L true NO783783L (no) | 1979-05-14 |
Family
ID=6023547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO783783A NO783783L (no) | 1977-11-11 | 1978-11-10 | Diagnostisk fremgangsmaate. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4212650A (da) |
| JP (1) | JPS5475885A (da) |
| AT (1) | ATA806078A (da) |
| AU (1) | AU4144478A (da) |
| BE (1) | BE871977A (da) |
| DD (1) | DD140503A5 (da) |
| DE (1) | DE2750521A1 (da) |
| DK (1) | DK501278A (da) |
| ES (1) | ES474810A1 (da) |
| FI (1) | FI783425A (da) |
| FR (1) | FR2408339A1 (da) |
| GB (1) | GB2007716B (da) |
| IT (1) | IT7829643A0 (da) |
| LU (1) | LU80499A1 (da) |
| NL (1) | NL7811184A (da) |
| NO (1) | NO783783L (da) |
| NZ (1) | NZ188867A (da) |
| SE (1) | SE7811576L (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS589060A (ja) * | 1981-07-09 | 1983-01-19 | Kureha Chem Ind Co Ltd | 電気泳動法による細胞の検査方法 |
| JPS60205263A (ja) * | 1984-03-30 | 1985-10-16 | Kureha Chem Ind Co Ltd | 電気泳動法による細胞の検査方法 |
| ES2143362B1 (es) * | 1997-02-28 | 2000-12-16 | Univ Valencia Politecnica | Aparato y metodo para caracterizar particulas polarizables por dielectroforesis. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE314227B (da) * | 1964-08-26 | 1969-09-01 | Lkb Produkter Ab | |
| SE316928B (da) * | 1966-11-25 | 1969-11-03 | Kabi Ab | |
| US3607695A (en) * | 1969-02-14 | 1971-09-21 | Pfizer & Co C | Hemoglobinopathy controls |
| US3708402A (en) * | 1970-10-19 | 1973-01-02 | Gen Electric | Measurements of particles and molecules |
| GB1388719A (en) * | 1971-09-02 | 1975-03-26 | Hadassah Medical Relief Ass In | Pure t-globulin and its anti-serum |
| DE2441536C3 (de) * | 1974-08-30 | 1980-09-11 | Behringwerke Ag, 3550 Marburg | Diagnostisches Verfahren |
| IT1055851B (it) * | 1974-08-30 | 1982-01-11 | Behringwerke Ag | Particelle indicatirci per diagnosi in vitro |
| US4043757A (en) * | 1975-05-20 | 1977-08-23 | Ortho Pharmaceutical Corporation | Method for detection of human mammary carcinoma |
| US3984533A (en) * | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4011044A (en) * | 1976-07-06 | 1977-03-08 | General Electric Company | Use of laser speckle patterns for measurement of electrophoretic mobilities |
-
1977
- 1977-11-11 DE DE19772750521 patent/DE2750521A1/de not_active Withdrawn
-
1978
- 1978-11-04 ES ES474810A patent/ES474810A1/es not_active Expired
- 1978-11-07 DD DD78208922A patent/DD140503A5/de unknown
- 1978-11-09 AU AU41444/78A patent/AU4144478A/en active Pending
- 1978-11-09 NZ NZ188867A patent/NZ188867A/xx unknown
- 1978-11-09 FI FI783425A patent/FI783425A/fi unknown
- 1978-11-09 JP JP13802378A patent/JPS5475885A/ja active Pending
- 1978-11-09 SE SE7811576A patent/SE7811576L/xx unknown
- 1978-11-09 IT IT7829643A patent/IT7829643A0/it unknown
- 1978-11-09 US US05/959,011 patent/US4212650A/en not_active Expired - Lifetime
- 1978-11-09 LU LU80499A patent/LU80499A1/de unknown
- 1978-11-10 DK DK501278A patent/DK501278A/da unknown
- 1978-11-10 NO NO783783A patent/NO783783L/no unknown
- 1978-11-10 NL NL7811184A patent/NL7811184A/xx not_active Application Discontinuation
- 1978-11-10 AT AT806078A patent/ATA806078A/de not_active Application Discontinuation
- 1978-11-13 GB GB7844214A patent/GB2007716B/en not_active Expired
- 1978-11-13 FR FR7831996A patent/FR2408339A1/fr not_active Withdrawn
- 1978-11-13 BE BE191700A patent/BE871977A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7811184A (nl) | 1979-05-15 |
| DE2750521A1 (de) | 1979-05-17 |
| DK501278A (da) | 1979-05-12 |
| JPS5475885A (en) | 1979-06-18 |
| NZ188867A (en) | 1981-10-19 |
| FR2408339A1 (fr) | 1979-06-08 |
| BE871977A (fr) | 1979-05-14 |
| AU4144478A (en) | 1979-05-17 |
| ATA806078A (de) | 1981-01-15 |
| FI783425A (fi) | 1979-05-12 |
| SE7811576L (sv) | 1979-05-12 |
| LU80499A1 (de) | 1979-06-15 |
| GB2007716B (en) | 1982-04-21 |
| US4212650A (en) | 1980-07-15 |
| IT7829643A0 (it) | 1978-11-09 |
| GB2007716A (en) | 1979-05-23 |
| ES474810A1 (es) | 1979-03-16 |
| DD140503A5 (de) | 1980-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McClure et al. | Immunochemical studies on thymosin: radioimmunoassay of thymosin alpha 1. | |
| Janssen et al. | Origin and biosynthesis of human tear fluid proteins. | |
| PROPP et al. | Waldenstrom's macroglobulinemia and neuropathy: Deposition of M‐component on myelin sheaths | |
| Johns et al. | A simple numerical method for the construction of isokinetic sucrose density gradients, and their application to the characterisation of immunoglobulin complexes | |
| Shirodaria et al. | Viral antibody titers: comparison in patients with multiple sclerosis and rheumatoid arthritis | |
| Fabricant et al. | Increased serum levels of nerve growth factor in von Recklinghausen's disease | |
| Lenkei et al. | Methods for detection of anti-albumin autoantibodies in hepatic diseases | |
| US5616685A (en) | snRNP-A antigen and fragments thereof | |
| Bailey et al. | Antigenic properties of pleuropneumonia-like organisms from tissue cell cultures and the human genital area | |
| Rocklin et al. | Activation of antigen-specific suppressor cells in human schistosomiasis mansoni by fractions of soluble egg antigens nonadherent to Con A sepharose. | |
| Söderström et al. | Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid. | |
| Phillips et al. | Isoelectric spectra of different classes of anti‐erythrocyte antibodies | |
| Jepson et al. | Decreased in vivo and in vitro erythropoiesis induced by plasma of ten patients with thymoma, lymphosarcoma, or idiopathic erythroblastopenia | |
| Tsang et al. | Serological diagnosis of typhoid fever by counterimmunoelectrophoresis. | |
| NO783783L (no) | Diagnostisk fremgangsmaate. | |
| Kline et al. | Developmental profile of chicken splenic lymphocyte responsiveness to Con A and PHA and studies on chicken splenic and bone marrow cells capable of inhibiting mitogen-stimulated blastogenic responses of adult splenic lymphocytes. | |
| CA1059902A (en) | Diagnostic process | |
| Keiser | Preparation of 125I‐labeled native DNA for use in radioimmunoassays for anti‐native‐DNA antibodies | |
| Berger et al. | Cirrhotic hyperglobulinemia: increased rates of immunoglobulin synthesis by circulating lymphoid cells | |
| Naylor et al. | Effect of thymosin and lipopolysaccharide on murine lymphocyte cyclic AMP | |
| Roszman et al. | A kinetic and quantitive analysis of antibody and protein synthesis during the primary response to keyhole limpet haemocyanin | |
| Kott et al. | Myasthenia gravis: Cellular response to basic myelin protein compared with cellular and humoral immunity to muscle antigens | |
| Rowland et al. | Myoglobin and muscular dystrophy: Electrophoretic and immunochemical study | |
| Reunanen et al. | Proliferation of multiple sclerosis cerebrospinal fluid lymphocytes after stimulation with measles virus antigens | |
| Petty et al. | The effects of stimulated lymphocyte supernatants on the electrophoretic mobility distribution of peritoneal macrophages |